NDC 0955-1022 – Docetaxel
Docetaxel 160 mg/8mL · Injection, Solution, Concentrate · Intravenous
Product NDC0955-1022
Product details
- Brand name
- Docetaxel
- Generic name
- Docetaxel
- Labeler
- Sanofi-Aventis U.S. LLC
- Dosage form
- Injection, Solution, Concentrate
- Route
- Intravenous
- Marketing category
- NDA AUTHORIZED GENERIC · NDA020449
- Marketed since
- October 23, 2016
- Listing expires
- December 31, 2026
- Pharmacologic class
- Microtubule Inhibitor
Active ingredients
- Docetaxel 160 mg/8mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0955-1022-08 | 1 VIAL, GLASS in 1 CARTON (0955-1022-08) / 8 mL in 1 VIAL, GLASS | Oct 23, 2016 |
Recalls mentioning this NDC
- D-0804-2018 May 9, 2018 · Class II
Superpotent drug: over-concentrated vials of Docetaxel injection concentrate 20 mg/mL may have been distributed.
Other Docetaxel products
- 16729-267 Docetaxel Anhydrous 20 mg/mL · Injection, Solution, Concentrate · Accord Healthcare Inc.
- 45963-734 Docetaxel 20 mg/mL · Injection, Solution, Concentrate · Actavis Pharma, Inc.
- 45963-765 Docetaxel 20 mg/mL · Injection, Solution, Concentrate · Actavis Pharma, Inc.
- 62332-678 Docetaxel Anhydrous 10 mg/mL · Injection · Alembic Pharmaceuticals Inc.
- 46708-678 Docetaxel Anhydrous 10 mg/mL · Injection · Alembic Pharmaceuticals Limited
- 70121-1222 Docetaxel Anhydrous 80 mg/4mL · Injection · Amneal Pharmaceuticals LLC
- 70121-1221 Docetaxel Anhydrous 20 mg/mL · Injection · Amneal Pharmaceuticals LLC
- 70121-1223 Docetaxel Anhydrous 160 mg/8mL · Injection · Amneal Pharmaceuticals LLC
- 43066-048 Docetaxel Anhydrous 10 mg/mL · Injection · Baxter Healthcare Corporation
- 43066-010 Docetaxel 10 mg/mL · Injection, Solution · Baxter Healthcare Corporation
- 43066-046 Docetaxel Anhydrous 10 mg/mL · Injection · Baxter Healthcare Corporation
- 43066-044 Docetaxel Anhydrous 10 mg/mL · Injection · Baxter Healthcare Corporation